Catherine Barnard, FBA, FLSW, FRSA is Professor of European law and fellow of Trinity College, Cambridge and Director of the Centre for European Legal Studies. She is the author of EU Employment Law ...

Healthcare is undergoing a quiet revolution. Paper trails are giving way to digital records, and AI scribes are becoming official note-takers of patient–clinician conversations. This shift from ...

Jamie works on the ethical, legal and societal challenges posed by scientific and technological innovation in the context of health as part of the Humanities team. Prior to joining the PHG Foundation, ...

Heather Kompart is a policy analyst in the biomedical science team at the PHG Foundation, where she focuses on integrating genomic technologies into healthcare to enhance diagnosis and treatment. Her ...

We are an exempt charity under the Charities Act 2011 and regulated by the Office for Students (OFS) as a connected institution of the University of Cambridge. We are also a registered company no.

Patricia is a Policy Analyst in the humanities team. She works on legal and ethical issues for data protection and data governance introduced by scientific health innovations. She is completing a PhD ...

Mike grew up in the Seattle area before beginning undergraduate study in 1999 at the University of Washington, where he graduated with BSc’s in biochemistry and economics. As a 19 year-old, Mike began ...

These plans have been a long time in the making. The intention to produce a strategy ‘to ensure the UK is able to offer a predictive, preventative and personalised health and care service for people ...

A recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI). The MHRA proposed new five-year ...

The Wellcome Trust recently announced that they are funding a research programme to investigate synthetic human genomes, and Laura Blackburn, PHG Foundation’s Head of Science, had the opportunity to ...

The rapid development, approval and roll out of multiple vaccines against SARS-CoV-2, the virus that causes COVID-19, is an impressive achievement for science and healthcare. The virus genome was ...